Shares of Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) were up 40.1% as of 11:34 a.m. EDT on Thursday. The biotech announced earlier in the day that it had signed a deal with Jenrin Discovery LLC for exclusive worldwide rights to develop and market drugs based on more than 600 compounds targeting the endocannabinoid system.The licensing deal with Jenrin Discovery was huge for Corbus because it provides a big boost to the biotech's pipeline.
Comment on Why Corbus Pharmaceuticals Holdings Is Flying High Today
newsfeedback@fool.com (Keith Speights), The Motley Fool
Thu, 09/20/2018 - 10:01am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more